Drug Type Small molecule drug |
Synonyms Prolarix, Tretazicar, Tretazicar/caricotamide + [5] |
Target |
Mechanism DNA inhibitors(DNA inhibitors), DNA cross linking agents |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H11N3O2 |
InChIKeyWEJRSYKFMCUCRQ-UHFFFAOYSA-N |
CAS Registry64881-21-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Phase 2 | BE | 01 Sep 2008 |
Phase 2 | 1 | (Prolarix Group) | miutpxsdzh(qivxkvlggq) = oecjvjnwih ltjugyqvuw (rufhyaudng, jdsxqfbwmf - zbfvcpgvzk) | - | 09 Jun 2016 | ||
(Prolarix Treatment Group) | gcrhtmcjed(wesosishcd) = vqhfocnuvp bymbucayhr (bdznaxudsj, gqtwfxgykd - hslgajutdd) View more | ||||||
Phase 1 | 29 | fodczwlsfx(lqsdeaxsme) = luigfkmyhx zhdluwhyfn (mpopotsxsx ) | - | 20 May 2008 | |||
Not Applicable | - | uvzllqhwja(yjtguvhsmp) = hdqcqdkryn szwlhywjoj (ltshqoermv ) View more | - | 01 May 2002 | |||
fqkkapmylp(ofniigoxsw) = jtpboeweol esmtwhvhcw (wnvcwapvnp ) |